pharmacy

Annabelle Rodd, a student from the Epigenomic Medicine Laboratory, Baker IDI Heart and Diabetes Institute discusses the principles of DNA-targeted phototherapy. The presentation provides a historical perspective of the use of phototherapy using plant extracts and solar radiation for the treatment of skin conditions such vitiligo. Modern phototherapy using chemical compounds (psoralens) and ultraviolet light (UVA) for the treatment of psoriasis and cutaneous T-cell lymphoma is also...

We are entering an age in which the complete genome information of individuals will be readily available. The availability of this information will result in a paradigm shift in medical research and in health care, including diagnosis and prevention. Due to rapid advances in the sequencing technology, the costs to determine the full genome of an individual person will soon drop below 1’000 dollars. The promise of ubiquitous availability of personal genome sequences poses opportunities...

Dr. Shannon Dunlay, Assistant Professor of Medicine at Mayo Clinic in Rochester, MN, discusses her article appearing in the April 2011 issue of Mayo Clinic Proceedings on medication adherence of patients in the community who have heart failure, available at: http://tinyurl.com/4q6hz23

Description: Drs Marie Brown and Jennifer Bussells, practicing internists in the Chicago, Illinois area discuss their article appearing in the April 2011 issue of Mayo Clinic Proceedings. Available at: http://tinyurl.com/6ees9ar regarding patient adherence to prescribed medications.

The story of how two behavioral neuroscience graduate students from Oregon Health & Science University conceived and constructed the very first "Synaptic Land", a game that helps kids learn about processes involved in neurotransmission. Since its debut at the Oregon Kids Judge! Neuroscience Fair held at OMSI in 2002, undergraduate and graduate students at many other universities have created their own versions of the Synaptic Land game (e.g., PENN, University of Scranton, California State...

The main objective of the AntiMal Integrated Project is to generate novel antimalarial drugs with potential for use in humans, specifically to progress candidate molecules to the “first time into humans” stage of drug development. To achieve this goal, leading groups of malaria researchers from Europe and Africa with expertise in malaria biology, chemotherapy and drug development have come together to exploit new scientific and political opportunities to secure the development of a...